17 results
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... cells, triggering insulin ... CKD Common Side Effects ... #Summary #DM2 # ... diabetes #endocrinology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... • Increases insulin-mediated ... #Metformin #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... in Type 1 Diabetes ... monitors in Type 1 Diabetes ... #Mellitus #DM2 ... #Medications #pharmacology
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
including most type 1 diabetics ... including most 2 diabetics ... Weight #Based #pharmacology ... endocrinology #diabetes ... #DM2
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... Management 1 INSULIN ... Glucophage) 2 INSULIN ... #Management #pharmacology ... #DM2 #DMII #Classification
TACROLIMUS - Side Effects Mnemonic

Tremor 
Alopecia 
Cardiovascular (HTN) 
Renal insufficiency 
Oncologic (Skin Cancer) 
Lipids (hyperlipidemia) 
Insulin
TACROLIMUS - Side Effects ... hyperlipidemia) Insulin ... dependent diabetes ... Seizures #Pharmacology
Effects on body weight of various classes of type-2 diabetes medications.
 - Metformin - Weight Loss
Effects on body ... classes of type-2 diabetes ... Weight Gain ++ - Insulin ... Weight Gain ++++ #diabetes ... weightgain #comparison #pharmacology
Metformin - First Line Treatment for Diabetes Type 2
• Start with initial dose of 500 mg
Treatment for Diabetes ... gastrointestinal (GI) adverse effects ... Indications #Titration #Pharmacology ... #Diabetes #DM2
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... ) Common Side Effects ... • Euglycemic diabetic ... #Summary #DM2 # ... diabetes #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... glucose-dependent insulin ... Receptor #Agonists #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology